Literature DB >> 25600834

MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.

Marta Wagner1, Maciej Sobczyński, Małgorzata Bilińska, Anna Pokryszko-Dragan, Małgorzata Cyrul, Piotr Kuśnierczyk, Monika Jasek.   

Abstract

CD40-CD40L interactions mediate T-dependent B cell response and efficient T cell priming. Therefore, genes encoding these molecules are attractive candidates for studies on autoimmune diseases, such as multiple sclerosis (MS), in which activated T and B cells are involved. Thus, we analyzed CD40 and CD40L mRNA expression in whole blood samples from MS patients and controls. Additionally, we examined the effect of three SNPs of CD40 (rs1883832C>T, rs11569343C>G, and rs752118C>T) and two SNPs of CD40L (rs3092923T>C and rs3092952A>G) on their mRNA expression. Our results showed that the rs1883832C>T SNP affects CD40 gene expression. Our analysis revealed that individuals possessing CT and TT genotypes (predisposing to MS) had decreased level of CD40 mRNA in comparison to those with CC. Moreover, we demonstrated the potential role of impaired CD40-CD40L interaction in developing of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25600834     DOI: 10.1007/s12031-015-0490-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  20 in total

Review 1.  Multiple sclerosis genetics.

Authors:  Stephen Sawcer; Robin J M Franklin; Maria Ban
Journal:  Lancet Neurol       Date:  2014-05-19       Impact factor: 44.182

2.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Authors: 
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

Review 3.  B cells in multiple sclerosis: good or bad guys?: An article for 28 May 2014 - World MS Day 2014.

Authors:  Franziska Hoffmann; Edgar Meinl
Journal:  Eur J Immunol       Date:  2014-05       Impact factor: 5.532

4.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

Review 6.  Not always the bad guys: B cells as regulators of autoimmune pathology.

Authors:  Simon Fillatreau; David Gray; Stephen M Anderton
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

7.  Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus.

Authors:  Eva Balada; Jesús Castro-Marrero; Lledó Felip; Josep Ordi-Ros; Miquel Vilardell-Tarrés
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Progress in multiple sclerosis genetics.

Authors:  An Goris; Ine Pauwels; Bénédicte Dubois
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

10.  Association of SNPs of CD40 gene with multiple sclerosis in Russians.

Authors:  Ekaterina Alekseevna Sokolova; Nadezhda Alekseevna Malkova; Denis Sergeevich Korobko; Aleksey Sergeevich Rozhdestvenskii; Anastasia Vladimirovna Kakulya; Elena Vladimirovna Khanokh; Roman Andreevich Delov; Fedor Alekseevich Platonov; Tatyana Yegorovna Popova; Elena Gennadievna Aref' eva; Natalia Nikolaevna Zagorskaya; Valentina Mikhailovna Alifirova; Marina Andreevna Titova; Inna Vadimovna Smagina; Svetlana Alksandrovna El' chaninova; Anna Valentinovna Popovtseva; Valery Pavlovich Puzyrev; Olga Georgievna Kulakova; Ekaterina Yur'evna Tsareva; Olga Olegovna Favorova; Sergei Gennadievich Shchur; Natalia Yurievna Lashch; Natalia Fyodorovna Popova; Ekaterina Valerievna Popova; Evgenii Ivanovich Gusev; Aleksey Nikolaevich Boyko; Yurii Sergeevich Aulchenko; Maxim Leonidovich Filipenko
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more
  6 in total

1.  CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation.

Authors:  Hanna J Lee; Angela Lombardi; Mihaela Stefan; Cheuk Wun Li; William B Inabnet; Randall P Owen; Erlinda Concepcion; Yaron Tomer
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

2.  CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.

Authors:  Ding Chen; Sara J Ireland; Gina Remington; Enrique Alvarez; Michael K Racke; Benjamin Greenberg; Elliot M Frohman; Nancy L Monson
Journal:  J Immunol       Date:  2016-10-26       Impact factor: 5.422

Review 3.  Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis.

Authors:  Isabelle Pastor Bandeira; André Eduardo de Almeida Franzoi; Giulia Murillo Wollmann; Washigton Luiz Gomes de Medeiros Junior; Wesley Nogueira Brandão; Jean Pierre Schatzmann Peron; Jefferson Becker; Osvaldo José Moreira Nascimento; Marcus Vinícius Magno Gonçalves
Journal:  Neurol Sci       Date:  2022-07-18       Impact factor: 3.830

4.  A SNP in 5' untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study.

Authors:  Hua-Tuo Huang; Jing Guo; Yang Xiang; Jian-Ming Chen; Hong-Cheng Luo; Lan-Qing Meng; Ye-Sheng Wei
Journal:  Genet Mol Biol       Date:  2017-06-05       Impact factor: 1.771

5.  The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels.

Authors:  Zuo-Liang Liu; Jing Hu; Xue-Fei Xiao; Yue Peng; Shang-Ping Zhao; Xian-Zhong Xiao; Ming-Shi Yang
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

6.  Analysis of Genetic Variation in CD40 and CD40L: Relationship with mRNA Relative Expression and Soluble Proteins in Acute Coronary Syndrome.

Authors:  D E Martínez-Fernández; J R Padilla-Gutiérrez; F Casillas-Muñoz; Emmanuel Valdés-Alvarado; Brenda Parra-Reyna; Maricela Aceves-Ramírez; J F Muñoz-Valle; U Zalapa Flores; J C Chávez Herrera; Y Valle
Journal:  J Immunol Res       Date:  2019-04-30       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.